- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (352)
7 result(s) found for: Flo.
Displaying page 1 of 1.
EudraCT Number: 2010-020827-28 | Sponsor Protocol Number: 191622-098 | Start Date*: 2011-06-10 | |||||||||||
Sponsor Name:Allergan Limited | |||||||||||||
Full Title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Single Treatment Cycle Study of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex in Subjects with Lateral Can... | |||||||||||||
Medical condition: Treatment of lateral canthal rhytides in the periorbital region (Crow's Feet Lines) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004214-96 | Sponsor Protocol Number: MEIN/15/Bil-PSR/002 | Start Date*: 2017-02-02 | |||||||||||
Sponsor Name:MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG SA | |||||||||||||
Full Title: Bilastine and inflammation: an explorative study in subjects affected by Parietaria J.-induced Rhinoconjunctivitis – The Bi-FLO study | |||||||||||||
Medical condition: Rhinoconjunctivitis induced by Parietaria J. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005235-96 | Sponsor Protocol Number: BTX0506 | Start Date*: 2005-12-09 |
Sponsor Name:Cranley Clinic | ||
Full Title: A Double-Blind Comparison of the Safety and Efficacy of Dysport® and BOTOX® (Botulinum Toxin Type A) in the Treatment of Female Subjects with Severe Glabellar Rhytids | ||
Medical condition: Severe glabellar rhytids | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-024379-15 | Sponsor Protocol Number: PaFLO | Start Date*: 2011-09-19 | |||||||||||
Sponsor Name:Charité - Universitätsmedizin Berlin | |||||||||||||
Full Title: Pazopanib with 5-Flourouracil, Leucovorin and Oxaliplatin (FLO) as 1st-line treatment in advanced gastric cancer; a randomized Phase II study. - The PaFLO study. | |||||||||||||
Medical condition: We will treat patients with locally advanced or metastatic gastric cancer or adenocarcinoma of the gastro-esophageal junction with no curable treatment option. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022810-26 | Sponsor Protocol Number: PERCAT01 Version 10, 31.01.2011 | Start Date*: 2011-03-16 | |||||||||||||||||||||
Sponsor Name:University Witten/Herdecke | |||||||||||||||||||||||
Full Title: MULTICENTER, OPEN-LABEL PHASE II STUDY TO EVALUATE THE EFFICACY OF A 2-CYCLE IMMUNOTHERAPY WITH THE TRI FUNCTIONAL BISPECIFIC ANTIBODY CATUMAXOMAB (ANTI EPCAM X ANTI-CD3) IN ADDITION TO SYSTEMIC CH... | |||||||||||||||||||||||
Medical condition: PERITONEAL CARCINOMATOSIS FROM GASTRIC OR COLORECTAL ADENOCARCINOMA | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004455-32 | Sponsor Protocol Number: IMB101-006 | Start Date*: 2021-02-16 |
Sponsor Name:Imbria Pharmaceuticals, Inc. | ||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Patients with Angina due to Coronary Syndrome | ||
Medical condition: Stable coronary artery disease (CAD) /Chronic coronary syndrome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) FI (Completed) DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003408-65 | Sponsor Protocol Number: | Start Date*: 2016-08-26 | ||||||||||||||||
Sponsor Name:University of Edinburgh [...] | ||||||||||||||||||
Full Title: Ulipristal acetate versus conventional management of heavy menstrual bleeding (HMB; including uterine fibroids): a randomised controlled trial and exploration of mechanism of action (UCON trial) | ||||||||||||||||||
Medical condition: Heavy menstrual bleeding | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
